Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors. 2018

Mohammad Ali Ahmaditaba, and Mohammad Hassan Houshdar Tehrani, and Afshin Zarghi, and Sorayya Shahosseini, and Bahram Daraei
Department of Pharmaceutical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

A new series of peptide-like derivatives containing different aromatic amino acids and possessing pharmacophores of COX-2 inhibitors as SO2Me or N3 attached to the para position of an end phenyl ring was synthesized for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. The synthetic reactions were based on the solid phase peptide synthesis method using Wang resin. One of the analogues, i.e., compound 2d, as the representative of these series was recognized as the most effective and the highest selective COX-2 inhibitor with IC50 value of 0.08 μM and COX-2 selectivity index of 351.2, among the other synthesized compounds. Molecular docking study was operated to determine possible binding models of compound 2d to COX-2 enzyme. The study showed that the p-azido-phenyl fragment of 2d occupied inside the secondary COX-2 binding site (Arg513, and His90). The structure-activity relationships acquired disclosed that compound 2d with 4-(azido phenyl) group as pharmacophore and histidine as amino acid gives the essential geometry to provide inhibition of the COX-2 enzyme with high selectivity. Compound 2d can be a good candidate for the development of new hits of COX-2 inhibitors.

UI MeSH Term Description Entries

Related Publications

Mohammad Ali Ahmaditaba, and Mohammad Hassan Houshdar Tehrani, and Afshin Zarghi, and Sorayya Shahosseini, and Bahram Daraei
March 2021, Archiv der Pharmazie,
Mohammad Ali Ahmaditaba, and Mohammad Hassan Houshdar Tehrani, and Afshin Zarghi, and Sorayya Shahosseini, and Bahram Daraei
August 2015, Molecules (Basel, Switzerland),
Mohammad Ali Ahmaditaba, and Mohammad Hassan Houshdar Tehrani, and Afshin Zarghi, and Sorayya Shahosseini, and Bahram Daraei
March 2007, Bioorganic & medicinal chemistry,
Mohammad Ali Ahmaditaba, and Mohammad Hassan Houshdar Tehrani, and Afshin Zarghi, and Sorayya Shahosseini, and Bahram Daraei
January 2017, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society,
Mohammad Ali Ahmaditaba, and Mohammad Hassan Houshdar Tehrani, and Afshin Zarghi, and Sorayya Shahosseini, and Bahram Daraei
November 2011, Bioorganic & medicinal chemistry,
Mohammad Ali Ahmaditaba, and Mohammad Hassan Houshdar Tehrani, and Afshin Zarghi, and Sorayya Shahosseini, and Bahram Daraei
June 2017, Bioorganic chemistry,
Mohammad Ali Ahmaditaba, and Mohammad Hassan Houshdar Tehrani, and Afshin Zarghi, and Sorayya Shahosseini, and Bahram Daraei
April 2017, Bioorganic & medicinal chemistry letters,
Mohammad Ali Ahmaditaba, and Mohammad Hassan Houshdar Tehrani, and Afshin Zarghi, and Sorayya Shahosseini, and Bahram Daraei
December 2019, Bioorganic & medicinal chemistry letters,
Mohammad Ali Ahmaditaba, and Mohammad Hassan Houshdar Tehrani, and Afshin Zarghi, and Sorayya Shahosseini, and Bahram Daraei
September 2010, Bioorganic & medicinal chemistry,
Mohammad Ali Ahmaditaba, and Mohammad Hassan Houshdar Tehrani, and Afshin Zarghi, and Sorayya Shahosseini, and Bahram Daraei
January 2018, Iranian journal of pharmaceutical research : IJPR,
Copied contents to your clipboard!